Document is current
Any future updates will be listed below
-
Authors
Yoshida, Tomomi M. https://orcid.org/0000-0003-4529-720X
Nguyen, Mytien https://orcid.org/0000-0001-7343-6882
Zhang, Le
Lu, Benjamin Y. https://orcid.org/0000-0001-8764-8384
Zhu, Biqing https://orcid.org/0000-0002-7428-6297
Murray, Katie N.
Mineur, Yann S.
Zhang, Cuiling
Xu, Di
Lin, Elizabeth
Luchsinger, Joseph
Bhatta, Sagar
Waizman, Daniel A. https://orcid.org/0000-0002-3690-7793
Coden, Mackenzie E.
Ma, Yifan
Israni-Winger, Kavita
Russo, Anthony https://orcid.org/0000-0002-0623-6618
Wang, Haowei
Song, Wenzhi
Al Souz, Jafar https://orcid.org/0000-0003-2345-2803
Zhao, Hongyu https://orcid.org/0000-0003-1195-9607
Craft, Joseph E. https://orcid.org/0000-0002-1368-6756
Picciotto, Marina R. https://orcid.org/0000-0002-4404-1280
Grutzendler, Jaime https://orcid.org/0000-0002-5000-243X
Distasio, Marcello
Palm, Noah W. https://orcid.org/0000-0001-7262-9455
Hafler, David A. https://orcid.org/0000-0003-4664-535X
Wang, Andrew https://orcid.org/0000-0002-6951-8081
- License Information
-
More Information
Article History
Received: 1 February 2024
Accepted: 16 April 2025
First Online: 28 May 2025
Competing interests
: D.A.H. has received research funding from Bristol Myers Squibb, Novartis, Sanofi and Genentech, and has been a consultant for Bayer Pharmaceuticals, Repertoire, Bristol Myers Squibb, Compass Therapeutics, EMD Serono, Genentech, Juno Therapeutics, Novartis, Proclara Biosciences, Sage Therapeutics and Sanofi Genzyme. A.W. has received research funding from NGM Biopharmaceuticals and AstraZeneca; has been a consultant for Seranova Bio, the Column Group and Soleil Labs; and is on the scientific advisory board for NGM Biopharmaceuticals.
